Adipose-Derived Stem Cells

ADSCs have higher proliferative capacity and are easier to expand in vitro, supporting their clinical practicality. Fat is favored as a practical source because it is accessible and can contain meaningful quantities of regenerative cells. ADSCs are presented as an alternative to bone marrow-derived MSCs because adipose tissue is easier to harvest and provides more abundant cells. The review aims to study how harvesting and preparation methods relate to clinical and patient-reported outcomes. A small fat sample is described as potentially yielding about ten million mesenchymal stem cells. ADSC-based therapies are gaining use in tissue repair for degenerative joints and tendon-related conditions despite limited evidence. The article argues that adipose stem cells may remain relatively young because they can stay dormant until needed. Adipose-derived stem cells are obtained from fat. The planned review focuses on clinical uses of ADSCs in orthopaedic surgery, especially adult shoulder surgery and rotator cuff procedures. Mesenchymal stem cells are presented as a key therapeutic cell type associated with several tissues and regenerative functions.